Emergence of Post COVID-19 Vaccine Autoimmune Diseases: A Single Center Study

References

• Baloch S, Baloch M, Zheng T, Pei X. The Coronavirus Disease 2019 (COVID-19) Pandemic. Tohoku J Exp Med. 2020;250(4):271–278. doi:10.1620/tjem.250.271
   PubMed Web of Science ®Google Scholar
• Covid19.who.int. 2022. WHO Coronavirus (COVID-19) Dashboard. Available at: https://covid19.who.int. Accessed 8, March, 2022.
   Google Scholar
• Polack FP, Thomas SJ, Kitchin N, et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N Engl J Med. 2020;383(27):2603–2615. doi:10.1056/NEJMoa2034577
   PubMed Web of Science ®Google Scholar
• Bernal L, Andrews N, Gower C, et al. Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study. BMJ. 2021;373:n1088. doi:10.1136/bmj.n1088
   PubMed Web of Science ®Google Scholar
• HHS.gov. 2022. COVID-19 Vaccines. Available at: https://www.hhs.gov/coronavirus/covid-19-vaccines/index.html. Accessed 9, March, 2022.
   Google Scholar
• Khehra N, Padda I, Jaferi U, et al. Tozinameran (BNT162b2) Vaccine: the Journey from Preclinical Research to Clinical Trials and Authorization. AAPS Pharm Sci Tech. 2021;22(5):172. doi:10.1208/s12249-021-02058-y
   PubMed Web of Science ®Google Scholar
• Salam AA, Al-Khraif RM, Elsegaey I, et al. COVID-19 in Saudi Arabia: an Overview. Front Public Health. 2022;9:736942. doi:10.3389/fpubh.2021.736942
   PubMed Web of Science ®Google Scholar
• Assiri A, Al-Tawfiq JA, Alkhalifa M, et al. Launching COVID-19 vaccination in Saudi Arabia: lessons learned, and the way forward. Travel Med Infect Dis. 2021;43:102119. doi:10.1016/j.tmaid.2021.102119
   PubMed Web of Science ®Google Scholar
• Ministry of Health (MOH). MOH Begins Vaccinating 12–18 Age Group with Pfizer Vaccine. Accessed 9, March 2022.; 2022. Available online: https://www.moh.gov.sa/en/Ministry/MediaCenter/News/Pages/News-2021-06-27-008.aspx.
   Google Scholar
• Saudi Public Health Authority. Accessed 18, September 2021. 2021 Available online: https://covid19.cdc.gov.sa/professionals-health-workers/interim-guidelines-for-The-use-of-sars-cov-2-vaccine/.
   Google Scholar
• Ministry of Health (MOH). MOH, First Dose of COVID-19 Vaccine is Available for Children Aged 5-11 Years. Accessed 9, March 2022. 2022. Available online: https://www.moh.gov.sa/en/Ministry/MediaCenter/News/Pages/News-2022-01-16-002.aspx.
   Google Scholar
• Reuters. 2022. Saudi Arabia: the latest coronavirus counts, charts and maps. Accessed 9, March 2022. Available online at: https://graphics.reuters.com/world-coronavirus-tracker-and-maps/countries-and-territories/saudi-arabia/.
   Google Scholar
• Sharif N, Alzahrani KJ, Ahmed SN, et al. Efficacy, Immunogenicity and Safety of COVID-19 Vaccines: a Systematic Review and Meta-Analysis. Front Immunol. 2021;12(714170):11. doi:10.3389/fimmu.2021.714170
   Google Scholar
• Alsaffar WA. The Effectiveness of COVID-19 Vaccines in Improving the Outcomes of Hospitalized COVID-19 Patients. Cureus. 2022;14,1(Jan):e21485. doi:10.7759/cureus.21485
   Google Scholar
• El-Shitany NA, Harakeh S, Badr-Eldin SM, et al. Minor to Moderate Side Effects of Pfizer-BioNTech COVID-19 Vaccine Among Saudi Residents: a Retrospective Cross-Sectional Study. Int J Gen Med. 2021;14:1389–1401. doi:10.2147/IJGM.S310497
   PubMed Web of Science ®Google Scholar
• Elrashdy F, Tambuwala MM, Hassan SS, et al. Autoimmunity roots of the thrombotic events after COVID-19 vaccination. Autoimmun Rev. 2021;20(11):102941. doi:10.1016/j.autrev.2021.102941
   PubMed Web of Science ®Google Scholar
• Lundstrom K, Barh D, Uhal BD, et al. COVID-19 Vaccines and Thrombosis-Roadblock or Dead-End Street? Biomolecules. 2021;11(7):1020. doi:10.3390/biom11071020
   PubMed Web of Science ®Google Scholar
• Aladdin Y, Shirah B. New-onset refractory status epilepticus following the ChAdOx1 nCoV-19 vaccine. J Neuroimmunol. 2021;357:577629. doi:10.1016/j.jneuroim.2021.577629
   PubMed Web of Science ®Google Scholar
• Alghamdi AN. BNT162b2 and ChAdOx1 SARS-CoV-2 Post-vaccination Side-Effects Among Saudi Vaccinees. Front med. 2021;8(760047):8. doi:10.3389/fmed.2021.760047
   Google Scholar
• Cari L, Alhosseini MN, Fiore P, et al. Cardiovascular, neurological, and pulmonary events following vaccination with the BNT162b2, ChAdOx1 nCoV-19, and Ad26.COV2.S vaccines: an analysis of European data. J Autoimmun. 2021;125:102742. doi:10.1016/j.jaut.2021.102742
   PubMed Web of Science ®Google Scholar
• Kharbanda EO, Haapala J, DeSilva M, et al. Spontaneous Abortion Following COVID-19 Vaccination During Pregnancy. JAMA. 2021;326(16):1629–1631. doi:10.1001/jama.2021.15494
   PubMed Web of Science ®Google Scholar
• Ng X, Betzler BK, Testi I, et al. Ocular Adverse Events After COVID-19 Vaccination. Ocul Immunol Inflamm. 2021;29(6):1216–1224. doi:10.1080/09273948.2021.1976221
   PubMed Web of Science ®Google Scholar
• Chen Y, Xu Z, Wang P, et al. New-onset autoimmune phenomena post-COVID-19 vaccination. Immunology. 2021. doi:10.1111/imm.13443
   Web of Science ®Google Scholar
• Tarawneh O, Tarawneh H. Immune thrombocytopenia in a 22-year-old post Covid-19 vaccine. Am J Hematol. 2021;96(5):E133–E134. doi:10.1002/ajh.26106
   PubMed Web of Science ®Google Scholar
• Bril F, Al Diffalha S, Dean M, et al. Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: causality or casualty? J Hepatol. 2021;75(1):222–224. doi:10.1016/j.jhep.2021.04.003
   PubMed Web of Science ®Google Scholar
• Finsterer J. Neurological side effects of SARS-CoV-2 vaccinations. Acta Neurol Scand. 2022;145(1):5–9. doi:10.1111/ane.13550
   PubMed Web of Science ®Google Scholar
• Riley D Care case report guidelines [Internet]. CARE Case Report Guidelines. 2013. Available from: https://www.care-statement.org/. Accessed February 24, 2023.
   Google Scholar
• Dunkle LM, Izikson R, Patriarca PA, Goldenthal KL, Cox M, Treanor JJ. Safety and Immunogenicity of a Recombinant Influenza Vaccine: a Randomized Trial. Pediatrics. 2018;141(5):e20173021. doi:10.1542/peds.2017-3021
   PubMed Web of Science ®Google Scholar
• Willison HJ, Jacobs BC, van Doorn PA. Guillain-Barré syndrome. Lancet. 2016;388(10045):717–727. doi:10.1016/S0140-6736(16)
   PubMed Web of Science ®Google Scholar
• Devigili G, Rinaldo S, Lombardi R, et al. Diagnostic criteria for small fibre neuropathy in clinical practice and Research. Brain. 2019;142(12):3728–3736. doi:10.1093/brain/awz333
   PubMed Web of Science ®Google Scholar
• Behzad S, Aghaghazvini L, Radmard AR, Gholamrezanezhad A. Extrapulmonary manifestations of COVID-19: radiologic and clinical overview. Clin Imaging. 2020;66:35–41. doi:10.1016/j.clinimag.2020.05.013
   PubMed Web of Science ®Google Scholar
• Han X, Ye Q. Kidney involvement in COVID-19 and its treatments. J Med Virol. 2021;93(3):1387–1395. doi:10.1002/jmv.26653
   PubMed Web of Science ®Google Scholar
• Vadalà M, Poddighe D, Laurino C, Palmieri B. Vaccination and autoimmune diseases: is prevention of adverse health effects on the horizon? EPMA J. 2017;8(3):295–311. doi:10.1007/s13167-017-0101-y
   PubMed Web of Science ®Google Scholar
• Kanduc D, Shoenfeld Y. Molecular mimicry between SARS-CoV-2 spike glycoprotein and mammalian proteomes: implications for the vaccine. Immunol Res. 2020;68(5):310–313. doi:10.1007/s12026-020-09152-6
   PubMed Web of Science ®Google Scholar
• Havla J, Schultz Y, Zimmermann H, Hohlfeld R, Danek A, Kümpfel T. First manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine. J Neurol. 2022;269(1):55–58. doi:10.1007/s00415-021-10648-w
   PubMed Web of Science ®Google Scholar
• Garrido I, Lopes S, Simões MS, et al. Autoimmune hepatitis after COVID-19 vaccine - more than a coincidence. J Autoimmun. 2021;125:102741. doi:10.1016/j.jaut.2021.102741
   PubMed Web of Science ®Google Scholar
• Nune A, Iyengar KP, Ish P, Varupula B, Musat CA, Sapkota HR. The Emergence of new-onset SLE following SARS-CoV-2 vaccination. QJM. 2021;114:10. doi:10.1093/qjmed/hcab229
   Web of Science ®Google Scholar
• Watad A, Gabriele M, Mahajna H, et al. Howard Amital and Dennis McGonagle, “Immune-Mediated Disease Flares or New-Onset Disease in 27 Subjects Following mRNA/DNA SARS-CoV-2 Vaccination”. Vaccines. 2021;9:435. doi:10.3390/vaccines9050435
   PubMed Web of Science ®Google Scholar
• Barbhaiya M, Levine J, Siegel C, Bykerk V, Jannat-Khah D, Mandl L. Adverse events and disease flares after SARS-CoV-2 vaccination in patients with systemic lupus erythematosus. Clin Rheumatol. 2021;41(5):1619–1622. doi:10.1007/s10067-021-05963-6
   PubMed Web of Science ®Google Scholar
• Obeid M, Fenwick C, Pantaleo G. Reactivation of IgA vasculitis after COVID-19 vaccination. Lancet Rheumatol. 2021;3(9):e617. doi:10.1016/S2665-9913(21)00211-3
   PubMedGoogle Scholar
• Marc E, Grossman MD. FACP1 | Gerald Appel MD2 | Alicia J. Little MD, PhD1 | Christine J. Ko MD, “Post-COVID-19 vaccination IgA vasculitis in an adult”. J Cutan Pathol. 2021;1–3.
   Web of Science ®Google Scholar
• Bostan E, Gulseren D, Gokoz O. New-onset leukocytoclastic vasculitis after COVID-19 vaccine. Int J Dermatol. 2021;60(10):1305–1306. doi:10.1111/ijd.15777
   PubMed Web of Science ®Google Scholar
• Park K, Miyake S, Tai C, Tseng M, Andeen NK, Kung VL. Letter regarding: “A case of gross Hematuria and IgA nephropathy fare-up following SARS-CoV-2 vaccination.”. Kidney Int Rep. 2021;6(8):2246–2247. doi:10.1016/j.ekir.2021.06.007
   PubMed Web of Science ®Google Scholar
• Naitlho A, Lahlou W, Bourial A, et al. A Rare Case of Henoch-Schönlein Purpura Following a COVID-19 Vaccine—Case Report. Clin Med. 2021:2618.
   Google Scholar
• Rahim SEG, Lin JT, Wang JC. A case of gross hematuria and IgA nephropathy flare-up following SARS-CoV-2 vaccination. Kidney Int. 2021;100:238. doi:10.1016/j.kint.2021.04.024
   PubMed Web of Science ®Google Scholar
• Maye JA, Chong HP, Rajagopal V, Petchey W. “Reactivation of IgA vasculitis following COVID-19 vaccination”. BMJ Case Rep. 2021;14:e247188. doi:10.1136/bcr-2021-247188
   PubMedGoogle Scholar
• Anderegg MA, Liu M, Saganas C, et al. De novo vasculitis after mRNA-1273 (Moderna) vaccination. Kidney Int. 2021;100:474.
   PubMed Web of Science ®Google Scholar
• Sekar A, Ruth Campbell JT, Tabbara J, Rastogi P. De novo vasculitis after mRNA-1273 (Moderna) vaccination. Kidney Int. 2021;100:473–474. doi:10.1016/j.kint.2021.05.017
   PubMed Web of Science ®Google Scholar
• Shakoor MT, Birkenbach MP, Lynch M. ANCA-associated vasculitis following Pfzer-BioNTech COVID-19 vaccine. Am J Kidney Dis. 2021;2:19–21.
   Google Scholar
• Villa M, Díaz-Crespo F. Pérez de José A et al (2021) A case of ANCA-associated vasculitis after AZD1222 (Oxford–AstraZeneca) SARS-CoV-2 vaccination: casualty or causality? Kidney Int. 2022;1:1–2.
   Google Scholar
• Gupta RK, Ellis BK. Concurrent anti-GBM nephritis and ANCA-mediated glomerulonephritis after second dose of SARS-CoV-2 mRNA vaccination. Kidney Int Rep. 2021;7:127–128. doi:10.1016/j.ekir.2021.10.020
   PubMed Web of Science ®Google Scholar
• David R, Hanna P, Kenneth Lee AR, Ritchie A. Relapsed ANCA associated vasculitis following Oxford AstraZeneca ChAdOx1-S COVID-19 vaccination: a case series of two patients. Nephrology. 2021;27:109–110. doi:10.1111/nep.13993
   PubMed Web of Science ®Google Scholar
• Conticini E, d’Alessandro M, Bergantini L. Bergantini L et al (2021) Relapse of microscopic polyangiitis after vaccination against COVID-19: a case report. J Med Virol. 2021;93(12):6439–6441. doi:10.1002/jmv.27192
   PubMed Web of Science ®Google Scholar
• Weintraub M, Ameer B, Sinha Gregory N. Graves Disease Following the SARS-CoV-2 Vaccine: case Series. J Investigative Med High Impact Case Rep. 2021;9:232470962110633. doi:10.1177/23247096211063356
   Web of Science ®Google Scholar
• Lui D, Lee K, Lee C, Lee A, Hung I, Tan K. Development of Graves’ Disease After SARS-CoV-2 mRNA Vaccination: a Case Report and Literature Review. Front Public Health. 2021;9.
   Web of Science ®Google Scholar
• Soltanpoor P, Norouzi G. Subacute thyroiditis following COVID‐19 vaccination. Clin Case Rep. 2021;9:10. doi:10.1002/ccr3.4812
   Web of Science ®Google Scholar
• Oyibo S. Subacute Thyroiditis After Receiving the Adenovirus-Vectored Vaccine for Coronavirus Disease (COVID-19). Cureus. 2021. doi:10.7759/cureus.16045
   Web of Science ®Google Scholar
• Kumar A, Quraishi M, Segal J, Raine T, Brookes M. COVID-19 vaccinations in patients with inflammatory bowel disease. Lancet Gastroenterol Hepatol. 2020;5(11):965–966. doi:10.1016/S2468-1253(20)30295-8
   PubMed Web of Science ®Google Scholar
• D’Amico F, Rabaud C, Peyrin-Biroulet L, Danese S. SARS- CoV-2 vaccination in IBD: more pros than cons. Nat Rev Gastroenterol Hepatol. 2021;18:1–3. doi:10.1038/s41575-021-00420-w
   PubMed Web of Science ®Google Scholar
• Elkharsawi A, Arnim U, Schmelz R, et al. SARS-CoV-2 vaccination does not induce relapses of patients with inflammatory bowel disease. Zeitschrift für Gastroenterologie. 2022;60(01):77–80. doi:10.1055/a-1710-3861
   PubMed Web of Science ®Google Scholar
• Weaver K, Zhang X, Dai X, et al. Impact of SARS-CoV-2 Vaccination on Inflammatory Bowel Disease Activity and Development of Vaccine-Related Adverse Events: results From PREVENT-COVID. Inflammatory Bowel Dis. 2021;28(10):1497.
   Web of Science ®Google Scholar
• Bril F, Al Diffalha S, Dean M, Fettig DM. Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: causality or casualty? J Hepatol. 2021;1:215.
   Google Scholar
• Avci E, Abasiyanik F. Autoimmune hepatitis after SARS-CoV-2 vaccine: new-onset or flare-up? J Autoimmun. 2021;125:102745. doi:10.1016/j.jaut.2021.102745
   PubMed Web of Science ®Google Scholar
• Camacho-Domínguez L, Rodríguez Y, Polo F, et al. COVID-19 vaccine and autoimmunity. J Translational Autoimmunity. 2022;5:100140.
   PubMedGoogle Scholar
• Erard D, Villeret F, Lavrut P, Dumortier J. Autoimmune hepatitis developing after COVID 19 vaccine: presumed guilty? Clin Res Hepatol Gastroenterol. 2021;46:101841. doi:10.1016/j.clinre.2021.101841
   PubMed Web of Science ®Google Scholar
• Cao Z, Gui H, Sheng Z, Xin H, Xie Q. Letter to the editor: exacerbation of autoimmune hepatitis after COVID‐19 vaccination. Hepatology. 2021;75(3):757–759. doi:10.1002/hep.32269
   PubMed Web of Science ®Google Scholar
• Torrente S, Castiella A, Garmendia M, Zapata E. Probable autoimmune hepatitis reactivated after COVID-19 vaccination. Gastroenterología y Hepatología. 2021:8485.
   Web of Science ®Google Scholar
• Cao L, Ren L. Acute disseminated encephalomyelitis after severe acute respiratory syndrome coronavirus 2 vaccination: a case report. Acta Neurol Belg. 2021;1:1–3. doi:10.1007/s13760-021-01608-2
   Google Scholar
• Ozgen Kenangil G, Ari BC, Guler C, Demir MK. Acute disseminated encephalomyelitis-like presentation after an inactivated coronavirus vaccine. Acta Neurol Belg. 2021;121(4):1089–1091. doi:10.1007/s13760-021-01699-x
   PubMed Web of Science ®Google Scholar
• Raknuzzaman M, Jannaty T, Hossain MB, Saha B, Dey SK, Shahidullah M. Post Covid 19 vaccination acute disseminated encephalomyelitis: a case report in Bangladesh. Int J Med SciClin Res Studies. 2021;3:21. doi:10.47191/ijmscrs/v1-i3-01
   Google Scholar
• Torrealba-Acosta G, Martin JC, Huttenbach Y, et al. Acute encephalitis, myoclonus and Sweet syndrome after mRNA-1273 vaccine. BMJ Case Rep. 2021;14(7):e243173. doi:10.1136/bcr-2021-243173
   PubMedGoogle Scholar
• Waheed S, Bayas A, Hindi F, Rizvi Z, Espinosa PS. Neurological complications of COVID-19: guillain-Barre syndrome following Pfizer COVID-19 vaccine. Cureus. 2021;13(2):e13426. doi:10.7759/cureus.13426
   PubMed Web of Science ®Google Scholar
• Márquez Loza AM, Holroyd KB, Johnson SA, Pilgrim DM, Amato AA. Guillain-Barré syndrome in the placebo and active arms of a COVID-19 vaccine clinical trial: temporal associations do not imply causality. Neurology. 2021;96(22):1052–1054. doi:10.1212/WNL.0000000000011881
   PubMed Web of Science ®Google Scholar
• Patel SU, Khurram R, Lakhani A, Quirk B. Guillain-Barre syndrome following the first dose of the chimpanzee adenovirus-vectored COVID-19 vaccine, ChAdOx1. BMJ Case Rep. 2021;14(4):e242956.
   PubMedGoogle Scholar
• Zhou P, Yang X-L, Wang X-G, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270–273. doi:10.1038/s41586-020-2012-7
   PubMed Web of Science ®Google Scholar
• Zhang W, Du R-H, Li B, et al. Molecular and serological investigation of 2019-ncov infected patients: implication of multiple shedding routes. Em Microbes Infect. 2020;9(1):386–389. doi:10.1080/22221751.2020.1729071]
   PubMed Web of Science ®Google Scholar